Status:
COMPLETED
Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Carcinoma, Renal Cell
Eligibility:
All Genders
18-85 years
Brief Summary
The goal is to study the impact of functional MRI and CT evaluation of changes in tumor vessels induced by anti-angiogenic treatment in patients with metastatic RCC. The hypothesis is that good respo...
Detailed Description
The aim is to evaluate the capacity of functional CT and functional MRI to measure reliable biomarkers capable of evaluating the efficacy of anti-angiogenic treatment. Patient and methods \- Patient...
Eligibility Criteria
Inclusion
- with metastatic RCC
- without previous recent antiangiogenic treatment
Exclusion
- severe renal insufficiency
- allergy to contrast agents
- pregnancy
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT00842790
Start Date
September 1 2008
End Date
July 1 2014
Last Update
October 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
service of oncology- HEGP
Paris, France, 75015